April 19, 2024Open Access

Using Apparent Diffusion Coefficient (ADC) of Endometrial Cancer MRI to Determine P53 Molecular Subtypes

Key Points

Key points are not available for this paper at this time.

Abstract

Endometrial Cancer (EC) is a highly heterogeneous cancer comprising both histological and molecular subtypes. Using a non-invasive modality method to trigger these subtypes as early as possible can aid clinicians in establishing individualized treatment.

Read Full Paperexternally

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Zhang et al. (Fri,) studied this question.

synapsesocial.com/papers/68e6e666b6db643587661b39 https://doi.org/https://doi.org/10.2174/0115734056289592240408061811

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Role of apparent diffusion coefficient (ADC) and MRI-derived parameters in identifying p53-abnormal subtypes of endometrial cancer2026
2Preoperative prediction of p53abn endometrial cancer molecular subtype using a T2-weighted MRI radiomics fusion model: A multi-center study.2026
3Determination of p53abn endometrial cancer: a multitask analysis using radiological-clinical nomogram on MRI2024 · 7 citations
4The value of multimodal functional magnetic resonance imaging in differentiating p53abn from p53wt endometrial carcinoma2024
5AI-based histopathology image analysis reveals a distinct subset of endometrial cancers2024 · 36 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper